Panus, Sarah Christina – Trademark Portfolio
Entity Type: 01
Panus, Sarah Christina holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include MARKETING WITH EMPATHY, BRAND STORYTELLING ACADEMY, and BRAND STORYTELLING BLUEPRINT. The owner is based in Maple Grove, MN.
13570 Grove Dr. #112
Maple Grove, MN 55311
Showing of trademarks Trademarks
Trademark Classifications
Panus, Sarah Christina's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Panus, Sarah Christina have?
Panus, Sarah Christina has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Panus, Sarah Christina file in?
Panus, Sarah Christina files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Panus, Sarah Christina's most well-known trademarks?
Panus, Sarah Christina's registered trademark portfolio includes well-known marks such as MARKETING WITH EMPATHY, BRAND STORYTELLING ACADEMY, and BRAND STORYTELLING BLUEPRINT. These are among 3 currently registered trademarks in the portfolio.
What is Panus, Sarah Christina's trademark registration success rate?
Panus, Sarah Christina has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.